Lanean...
Chromatin structure predicts epigenetic therapy responsiveness in sarcoma
To formally explore the potential therapeutic effect of histone deacetylase inhibitors (HDACIs) and DNA-methyltransferase inhibitors (DNA-MIs) on sarcomas, we treated a large sarcoma cell line panel with five different HDACIs in the absence and presence of the DNA-MI decitabine. We observed that the...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2011
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3075587/ https://ncbi.nlm.nih.gov/pubmed/21216937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-10-0724 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|